FHC
GBIO

First Horizon Corporation’s Generation Bio GBIO Stock Holding History

First Horizon Corporation’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$0 Buy
+1
New +$299 ﹤0.01% 1120

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

First Horizon Corporation's GBIO Position: Q2 2021 in Review

First Horizon Corporation opened a new position in Generation Bio (GBIO) in Q2 2021: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1120 among its holdings.

97 funds tracked by Wall St. Rank hold GBIO as of Q2 2021.

  • First Horizon Corporation held 1 share of Generation Bio worth $0 as of Q2 2021.
  • Generation Bio was a new First Horizon Corporation position in Q2 2021.
  • Generation Bio made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2021, its #1120 holding.
  • 97 funds tracked by Wall St. Rank held Generation Bio as of Q2 2021.

Based on First Horizon Corporation's 13F filing for Q2 2021, filed 9 Aug 2021.